The European Patent Office (EPO) has published patent application EP2026029587A1, detailing a novel microorganism engineered with a foreign lipoate metabolic gene. This genetically modified organism is designed for the efficient production of pantothenic acid or tryptophan. The publication date for this patent application is March 18, 2026, and it is designated for use in multiple European countries.

This patent represents a new development in biotechnology for the synthesis of essential compounds. Companies involved in pharmaceutical manufacturing, biotechnology, and chemical synthesis may find this patent relevant for potential licensing or as a basis for further research and development. As this is a patent publication, it does not impose immediate compliance obligations but rather grants exclusive rights to the patent holder.